Recent Findings Preliminary data suggest that GLP-1 RA can modulate crucial pathways in the pathogenesis of IBD, such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity
Laboratory studies suggest the peptide interacts with systems involved in nitric oxide signaling, vascular regulation, and cellular movement
What happens after tirzepatide is discontinued
Think of these as the at-home care that complements the powerful work we do together in the clinic, helping you achieve a holistic and lasting transformation from the inside out
Oral semaglutide for weight loss has emerged as a groundbreaking treatment for those looking for a convenient alternative to injections
World J Gastrointestinal Surg